Sugi Predict

Sugi Predict / Compounds / SCHEMBL131604

SCHEMBL131604

SCHEMBL131604

[O]CCCc1ccc2ccccc2c1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.62
▸ SIGMAR1 Q99720 3/20 0.59
▸ HDAC1 Q13547 1/20 0.54
▸ HDAC8 Q9BY41 1/20 0.54
▸ CYP2A6 P11509 1/20 0.52
▸ HRH3 Q9Y5N1 1/20 0.49
▸ MC4R P32245 1/20 0.46
▸ MC5R P33032 1/20 0.46
▸ HCAR2 Q8TDS4 1/20 0.46
▸ SLC13A5 Q86YT5 1/20 0.45
▸ PDPK1 O15530 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130489 0.94 CYP1A2 (0.61) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL16414518 0.94 CYP1A2 (0.56) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL129284 0.92 HDAC1 (0.59) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL133000 0.92 HDAC1 (0.59) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL467397 0.92 HDAC1 (0.59) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL4486001 0.92 HDAC1 (0.59) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL15352037 0.88 CYP1A2 (0.54) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL131160 0.87 CYP1A2 (0.56) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL30746339 0.87 SIGMAR1 (0.68) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6
SCHEMBL30418669 0.87 SIGMAR1 (0.68) CYP1A2SIGMAR1HDAC1HDAC8CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240240226-A1 FLUOROGENIC ASSAY FOR RAPID SCREENING OF BACTERIAL BETA-LACTAMASE ACTIVITY UNIV LELAND STANFORD JUNIOR (US) 2024-07-18 — — US disclosed
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 — — EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 — — US disclosed
EP-3689891-B1 COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION UNIV KYUSHU NAT UNIV CORP (JP) 2023-03-01 — — EP disclosed
CN-107406476-B Mononuclear iron complex and organic synthesis reaction using same 国立大学法人九州大学 2021-07-27 — — CN disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 — — US disclosed
EP-3020715-B1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2021-06-16 — — EP disclosed
EP-3059235-B1 TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS SUMITOMO CHEMICAL CO (JP) 2020-10-28 — — EP disclosed
US-20200247957-A1 COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2020-08-06 — — US disclosed
EP-3689891-A1 COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION Kyushu University, National University Corporation (JP) 2020-08-05 — — EP disclosed
EP-0603225-B1 PROCESS FOR PRODUCING alpha-CHLOR-METHYLEN-TRIORGANYLPHOSPHORANE DERIVATES BASF AG (DE) 1997-06-04 — — EP disclosed
EP-0726903-A1 MATRIX METALLOPROTEASE INHIBITORS SYNTEX INC (US) 1996-08-21 — — EP disclosed
WO-1996023791-A1 BRIDGED INDOLES AS MATRIX METALLOPROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-08-08 — — WO disclosed
WO-1996016027-A1 MATRIX METALLOPROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-05-30 — — WO disclosed
EP-0712403-A1 MATRIX METALLOPROTEASE INHIBITORS SYNTEX INC (US) 1996-05-22 — — EP disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 — — EP disclosed
WO-1995012603-A1 MATRIX METALLOPROTEASE INHIBITORS________________________________ SYNTEX (U.S.A.) INC. (US) 1995-05-11 — — WO disclosed
WO-1995004735-A1 MATRIX METALLOPROTEASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-02-16 — — WO disclosed
WO-1993005053-A1 PROCESS FOR PRODUCING α-CHLOR-METHYLEN-TRIORGANYLPHOSPHORANE DERIVATES BASF AKTIENGESELLSCHAFT (DE) 1993-03-18 — — WO disclosed
EP-0498680-A1 New beta-amino-alpha-hydroxycarboxylic acids and their use Sankyo Company Limited (JP) 1992-08-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 CYP1A2 4682/4885SIGMAR1 4136/4885HDAC1 240/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 CYP1A2 4682/4885SIGMAR1 4136/4885HDAC1 240/4885
US-20200247957-A1 COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION OR51E2, WEE2, SLC39A11 CYP1A2 1362/4885SIGMAR1 616/4885HDAC1 306/4885
US-20240240226-A1 FLUOROGENIC ASSAY FOR RAPID SCREENING OF BACTERIAL BETA-LACTAMASE ACTIVITY CDA, CMBL, CTSF CYP1A2 485/4885SIGMAR1 3002/4885HDAC1 4042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.